# Joaquı́n Mateo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joaqu-n-mateo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,558 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 60 |
| i10-index | 129 |
| Last Known Institution | Hebron University |
| OpenAlex ID | https://openalex.org/A5037380661 |
| ORCID iD | https://orcid.org/0000-0001-5336-2548 |
| Works | 477 |

## Researcher papers

- [Integrative Clinical Genomics of Advanced Prostate Cancer](https://scholariq.org/papers/integrative-clinical-genomics-of-advanced-prostate-cancer/)
- [Olaparib for Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/olaparib-for-metastatic-castration-resistant-prostate-cancer/)
- [DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer](https://scholariq.org/papers/dna-repair-defects-and-olaparib-in-metastatic-prostate-cancer/)
- [Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer](https://scholariq.org/papers/inherited-dna-repair-gene-mutations-in-men-with-metastatic-prostate-cancer/)
- [Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group](https://scholariq.org/papers/recommendations-for-the-use-of-next-generation-sequencing-ngs-for-patients-with/)
- [Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/survival-with-olaparib-in-metastatic-castration-resistant-prostate-cancer/)
- [Delivering precision oncology to patients with cancer](https://scholariq.org/papers/delivering-precision-oncology-to-patients-with-cancer/)
- [Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-metastatic-and-or/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

## Researcher university

- [Hebron University](https://scholariq.org/institutions/hebron-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.